On Thursday, June 6, 2019, a consortium of New York City’s leading cancer care providers are coming together to launch the New York Proton Center, at —a $300 million, 140,000-square-foot facility at 225 East 126th Street in East Harlem. Combining the clinical excellence of Memorial Sloan Kettering Cancer Center, Montefiore Health System, and Mount Sinai Health System with proton beam technology available at only a few other centers in the world, the New York Proton Center will be a valuable resource for patients in the New York metro region and a beacon of top-quality cancer treatment in the U.S.
The center begins treating patients in July and expects to treat about 1,400 patients annually. Proton therapy is an ultra-precise form of radiation therapy that can spare patients the side-effects resulting from traditional radiation by minimizing damage to surrounding normal tissues and organs. It has been shown to be highly effective in treating a range of cancers.
Among the 30 proton centers in operation across the country, the New York Proton Center will be one of the largest and most technologically sophisticated. Most comparable facilities open with a staff of one or two trained specialists; this center will employ 23 protons, therapy-trained radiation oncologists. The center will also feature innovative “second generation” proton technology, including pencil beam scanning that allows for optimal treatment of complex tumors, and volumetric imaging that helps physicians precisely target cancers to millimeter accuracy.
In addition to offering a seamless, first-class patient experience, the New York Proton Center will lead and participate in multiple clinical trials examining the effectiveness of proton therapy compared to standard radiation. Beginning this summer there will be studies looking at breast, prostate, and head and neck cancers.
The New York Proton Center is an anchor of the 125th Street Development Project, a New York City Economic Development Corporation initiative aimed at revitalizing East Harlem as a dynamic hub of innovation.
The New York Proton Center is creating the gold standard for proton therapy, giving new hope to patients living with cancer. In partnership with leading academic medical centers—Memorial Sloan Kettering Cancer Center, Montefiore Health System, Mount Sinai Health System, and ProHEALTH as manager—the New York Proton Center brings together expert oncologists, clinical care teams, and researchers to improve cancer care and advance the clinical evidence for proton therapy.
For additional information, please visit www.nyproton.com.
Photo credit: Prakash Patel photography.